Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T02:28:31.116Z Has data issue: false hasContentIssue false
  • English
  • Français

Overnight urinary cortisol release in women with borderline personality disorder depends on comorbid PTSD and depressive psychopathology

Published online by Cambridge University Press:  16 April 2020

Katja Wingenfeld ,
Martin Driessen ,
Bettina Adam  and
Andreas Hill
Katja Wingenfeld*
Affiliation:
Department of Psychiatry and Psychotherapy Bethel, Ev. Hospital Bielefeld, Remterweg 69-71, D-33617Bielefeld, Germany
Martin Driessen
Affiliation:
Department of Psychiatry and Psychotherapy Bethel, Ev. Hospital Bielefeld, Remterweg 69-71, D-33617Bielefeld, Germany University of Schleswig-Holstein, Campus Luebeck, Germany University of Bielefeld, Bielefeld, Germany
Bettina Adam
Affiliation:
University of Schleswig-Holstein, Campus Luebeck, Germany August-Bier-Hospital, Bad Malente-Gremsmühlen, Germany
Andreas Hill
Affiliation:
University of Schleswig-Holstein, Campus Luebeck, Germany Institute of Sexology and Forensic Psychiatry, Center for Psychosocial Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
*
*Corresponding author. Tel.: +49 521 772 78522; fax: +49 521 772 78511. E-mail address: [email protected] (K. Wingenfeld).
Get access

Abstract

Free cortisol was investigated in BPD patients and healthy controls. A positive association was found between cortisol and depression scores, while the number of PTSD symptoms was negatively correlated with cortisol release. These findings suggest that alterations in cortisol release in BPD are strongly associated with the severity of psychopathology.

Keywords

Borderline personality disorderPTSDCortisolHPA axisChildhood trauma
Type
Short communication
Information
European Psychiatry , Volume 22 , Issue 5 , July 2007 , pp. 309 - 312
Copyright
Copyright © Elsevier Masson SAS 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Antonijevic, I.A.Depressive disorders – is it time to endorse different pathophysiologies?. Psychoneuroendocrinology 2006;31:1–15.CrossRefGoogle ScholarPubMed
Baker, D.G., Ekhator, N.N., Kasckow, J.W., Dashevsky, B., Horn, P.S., Bednarik, L.et al.Higher levels of basal serial CSF cortisol in combat veterans with post-traumatic stress disorder. Am J Psychiatry 2005;162:992–994.CrossRefGoogle Scholar
Baxter, L., Edell, W., Gerner, R., Fairbanks, L., Gwirtsman, H.Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder. J Clin Psychiatry 1984;45:150–153.Google ScholarPubMed
Beck, A.T., Steer, R.A.Beck-Depressions-Inventar: BDI. Testhandbuch Bern: Huber; 1994.Google Scholar
Bernstein, D., Fink, L.CTQ childhood trauma questionnaire: a retrospective self-report. San Antonio: The Psychological Corporation; 1998.Google Scholar
Delahanty, D.L., Nugent, N.R., Christopher, N.C., Walsh, M.Initial urinary epinephrine and cortisol levels predict acute PTSD symptoms in child trauma victims. Psychoneuroendocrinology 2005;30:1994. p. 121–128.CrossRefGoogle ScholarPubMed
Driessen, M., Beblo, T., Reddemann, L., Rau, H., Lange, W., Silva, A.et al.Ist die Borderline-Persönlichkeitsstörung eine komplexe posttraumatischen Belastungsstörung?. Nervenarzt 2002;73:820–829.CrossRefGoogle Scholar
Glover, D.A., Poland, R.E.Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 2002;27:805–819.CrossRefGoogle ScholarPubMed
Heim, C., Nemeroff, C.B.Neurobiology of early life stress: clinical studies. Semin Clin Neuropsychiatry 2002;7:147–159.CrossRefGoogle ScholarPubMed
Heim, C., Newport, D.J., Wagner, D., Wilcox, M.M., Miller, A.H., Nemeroff, C.B.The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety 2002;15:117–125.CrossRefGoogle ScholarPubMed
Johnson, J.G., Cohen, P., Brown, J., Smailes, E.M., Bernstein, D.P.Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry 1999;56:600–606.CrossRefGoogle ScholarPubMed
Krishnan, K.R., Davidson, J.R., Rayasam, K., Shope, F.The dexamethasone suppression test in borderline personality disorder. Biol Psychiatry 1984;19:1149–1153.Google ScholarPubMed
Lahmeyer, H.W., Val, E., Gaviria, F.M., Prasad, R.B., Pandey, G.N., Rodgers, P.et al.EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Res 1988;25:19–30.CrossRefGoogle ScholarPubMed
Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A.S., Mensebach, C.et al.Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 2005;30:919–923.CrossRefGoogle ScholarPubMed
Lieb, K., Rexhausen, J.E., Kahl, K.G., Schweiger, U., Philipsen, A., Hellhammer, D.H.et al.Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res 2004;38:559–565.CrossRefGoogle ScholarPubMed
Mason, J.W., Wang, S., Yehuda, R., Lubin, H., Johnson, D., Bremner, J.D.et al.Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosom Med 2002;64:238–246.CrossRefGoogle ScholarPubMed
Newport, D.J., Heim, C., Bonsall, R., Miller, A.H., Nemeroff, C.B.Pituitary–adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 2004;55:10–20.CrossRefGoogle ScholarPubMed
Ogata, S.N., Silk, K.R., Goodrich, S., Lohr, N.E., Westen, D., Hill, E.M.Childhood sexual and physical abuse in adult patients with borderline personality disorder. Am J Psychiatry 1990;147:1008–1013.Google ScholarPubMed
Pariante, C.M., Miller, A.H.Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001;49:391–404.CrossRefGoogle ScholarPubMed
Raadsheer, F.C., van Heerikhuize, J.J., Lucassen, P.J., Hoogendijk, W.J., Tilders, F.J., Swaab, D.F.Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372–1376.Google ScholarPubMed
Rinne, T., de Kloet, E.R., Wouters, L., Goekoop, J.G., DeRijk, R.H., van den Brink, W.Hyperresponsiveness of hypothalamic–pituitary–adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry 2002;52:1102–1112.CrossRefGoogle ScholarPubMed
Rohleder, N., Joksimovic, L., Wolf, J.M., Kirschbaum, C.Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004;55:745–751.CrossRefGoogle ScholarPubMed
Soloff, P.H., George, A., Nathan, R.S.The dexamethasone suppression test in patients with borderline personality disorders. Am J Psychiatry 1982;139:1621–1623.Google ScholarPubMed
Southwick, S.M., Axelrod, S.R., Wang, S., Yehuda, R., Morgan, C.A., Charney, D.et al.Twenty-four-hour urine cortisol in combat veterans with PTSD and comorbid borderline personality disorder. 3rdJ Nerv Ment Dis 2003;191:261–262.CrossRefGoogle ScholarPubMed
Wittchen, H.U., Zaudig, M., Fydrich, T.Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID-I Hogrefe; 1997.Google Scholar
Yehuda, R.Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 2002;25:341–368 vii.CrossRefGoogle ScholarPubMed
Young, E.A., Breslau, N.Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 2004;61:394–401.CrossRefGoogle ScholarPubMed
Zanarini, M.C., Frankenburg, F.R., Dubo, E.D., Sickel, A.E., Trikha, A., Levin, A.et al.Axis I comorbidity of borderline personality disorder. Am J Psychiatry 1998;155:1733–1739.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.